Patent details

Basic Information

Publication number:

EP1149579

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP013034814

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of an estrogen agonist/antagonist for treating female sexual dysfunction

French Title of Invention:

Utilisation d'un agoniste/antagoniste estrogénique pour traiter le dysfonctionnement sexuel chez la femme

German Title of Invention:

Verwendung von einem Östrogen Agonist/Antagonist zur Behandlung der weiblichen sexuellen Störungen

SPC Number:

Dates

Filing date:

12/04/2001

Grant date:

06/12/2006

EP Publication Date:

06/12/2006

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/10/2001

EP B1 Publication Date:

06/12/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/04/2009

Expiration date:

12/04/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/04/2001

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

06/12/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Day Wesley Warren, Pfizer Global

Address:

United States (US)

2

Name:

Lee Andrew George, Pfizer Global

Address:

United States (US)

3

Name:

Thompson David Duane, Pfizer Global

Address:

United States (US)

Priority

Priority Number:

266387 P

Priority Date:

18/04/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/00;

Filing date	Document type	Number of pages